Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Boxed Warnings and Off-Label Use of Allergy...
Journal article

Boxed Warnings and Off-Label Use of Allergy Medications: Risks, Benefits, and Shared Decision Making

Abstract

The Food and Drug Administration is tasked with evaluating the efficacy and safety of a drug. Despite having a regimented appraisal process in place, safety evidence can emerge during clinical trials as well as from observations and studies conducted after the drug has been on the market, which might require a boxed warning. The boxed warning is the most severe warning that the Food and Drug Administration can give to an approved drug. It is …

Authors

Greiwe J; Honsinger R; Hvisdas C; Chu DK; Lang DM; Nicklas R; Apter AJ

Journal

The Journal of Allergy and Clinical Immunology In Practice, Vol. 10, No. 12, pp. 3057–3063

Publisher

Elsevier

Publication Date

December 2022

DOI

10.1016/j.jaip.2022.08.033

ISSN

2213-2198